# Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)

> **NCT03143491** · PHASE2 · WITHDRAWN · sponsor: **DFB Soria, LLC**

## Conditions studied

- Cervical Intraepithelial Neoplasia

## Interventions

- **DRUG:** SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment

## Key facts

- **NCT ID:** NCT03143491
- **Lead sponsor:** DFB Soria, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never initiated
- **Last updated:** 2017-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03143491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03143491, "Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03143491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*